Meng Mou Biology

BiotechnologyAngelChengdu, China

Latest round

Angel

Last raised

Sep 2023

Total raised

Undisclosed

Investors

1

About Meng Mou Biology

, dba Meng Mou Biology and Moucellion, is a biotech company that focuses on developing drugs for degenerative eye diseases. As of 2023, the company has established a research and development, process development and quality management team of dozens of people. It has cooperated with Beijing Tongren Hospital affiliated to Capital Medical University and Beijing Eye Institute. The company has technologies such as in vitro induced reprogramming and in vitro induced differentiation of induced pluripotent stem cells (iPSC) and AAV vector optimization. It is committed to using stem cells and gene therapies to treat eye diseases. The company generates revenue from providing stem cells and gene therapies to treat eye diseases.

Who invested in Meng Mou Biology

1 investor across 1 round

See all investors in Meng Mou Biology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Sep 18, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about Meng Mou Biology

Who invested in Meng Mou Biology?

Meng Mou Biology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Meng Mou Biology raised?

Meng Mou Biology has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Meng Mou Biology last raise money?

Meng Mou Biology's most recent round on record is a Angel, in Sep 2023.

What does Meng Mou Biology do?

, dba Meng Mou Biology and Moucellion, is a biotech company that focuses on developing drugs for degenerative eye diseases.

Where is Meng Mou Biology headquartered?

Meng Mou Biology is headquartered in Chengdu, China.

Which VCs invest in companies like Meng Mou Biology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Meng Mou Biology's stage. Their profiles are linked below.

Raising like Meng Mou Biology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.